Lymphoma Clinical Trials in Fuzhou
6 recruitingFuzhou, China
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Untreated Follicular Lymphoma
AstraZeneca1,018 enrolled135 locationsNCT06549595
Recruiting
Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Diffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+4 more
Janssen Research & Development, LLC700 enrolled174 locationsNCT01804686
Recruiting
Phase 3
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Lymphoma
Hoffmann-La Roche182 enrolled75 locationsNCT06084936
Recruiting
Phase 1
Study of AXT-1003 in Subjects With Advanced Malignant Tumors.
Advanced Solid TumorNon-Hodgkin Lymphoma
Axter Therapeutics (Beijing) Co., Ltd78 enrolled5 locationsNCT06484985
Recruiting
Phase 2
Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Diffuse Large B-Cell Lymphoma (DLBCL)
Xynomic Pharmaceuticals, Inc.170 enrolled23 locationsNCT03936153
Recruiting
Phase 3
A Global Phase 3 Study of Orelabrutinib+BR Vs.BR in Pts with TN MCL
Mantle Cell Lymphoma
InnoCare Pharma Inc.476 enrolled39 locationsNCT06363994